Sorted By:

Relevance


Australia is making it harder to protect inventions. That’s bad for American businesses and jobs.

PhRMA  |  Blog Post

U.S. innovators should not be unfairly penalized for enforcing their patents—and the U.S. government must put a stop to these practices.
http://catalyst.phrma.org/australia-is-making-it-harder-to-protect-inventions.-thats-bad-for-american-businesses-and-jobs

Protect Your Health: Important Disaster Preparedness Tips for Harvey and Irma

PhRMA  |  Blog Post

Be aware of the closest provider, pharmacy and emergency department.
http://catalyst.phrma.org/protect-your-health-important-disaster-preparedness-tips-for-harvey-and-irma

4 Things to know about the QuintilesIMS Medicines Use and Spending in the U.S. report

PhRMA  |  Blog Post

Learn more about the cost and value of medicines at phrma.org/cost.
http://catalyst.phrma.org/4-things-to-know-about-the-quintilesims-medicines-use-and-spending-in-the-us-report

More Than 50 Medicines and Vaccines in Development for HIV Infection, Treatment and Prevention

PhRMA  |  Press Release

About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives.
https://www.phrma.org

The Importance of Risk Evaluation and Mitigation Strategies

PhRMA  |  Fact Sheet

Food and Drug Administration (FDA) may require based on the safety profile of a new medicine or new safety information for a previously approved medicine.
https://www.phrma.org/fact-sheet/the-importance-of-risk-evaluation-and-mitigation-strategies

New data put medicine costs and spending in context

PhRMA  |  Blog Post

Biopharmaceutical companies invested about $75 billion in research and development (R&D) in 2015 and, on average, reinvest 20 percent of revenues into R&D.
http://catalyst.phrma.org/new-data-put-medicine-costs-and-spending-in-context

Legislative and Regulatory History of the Evolution of 340B Program

PhRMA  |  Fact Sheet

The 340B program was created by Congress in 1992 to help vulnerable or uninsured patients access prescription medicines at safety net facilities. Learn the history of the evolution of this program....
https://www.phrma.org/fact-sheet/legislative-and-regulatory-history-of-the-evolution-of-340b-program

PhRMA Statement on Clinical Trials and Bad Pharma

PhRMA  |  Press Release

About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research and biotechnology companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/phrma-statement-on-clinical-trials-and-bad-pharma

Survey Finds Variability in MS Treatment Preferences Among Individual Patients, and Among Stakeholder Groups.

PhRMA  |  Fact Sheet

Real Endpoints, LLC (RE), a data analytics firm focusing on assessing and quantifying pharmaceutical value, has just completed an extensive literature review and survey to tease out how different stakeholder groups assess the value of current multiple sclerosis (MS) therapies.
https://www.phrma.org/fact-sheet/survey-finds-variability-in-ms-treatment-preferences-among-individual-patients-and-among-stakeholder-groups

Manager – Advocacy and Strategic Alliances (State)

PhRMA  |  PhRMA Career

We are committed to the growth and development of our team members and offer many learning opportunities such as tuition reimbursement at both the undergraduate and graduate levels, industry on-site and off-site training, PhRMAcademy lunch and learn sessions, presentation skills, performance management and other management/professional develop programs. 
https://www.phrma.org

Johnson & Johnson, Pfizer, Walgreens and other CEOs discuss value in the future of health care

PhRMA  |  Blog Post

Margolis professor of business, medicine and policy and director, Duke-Margolis Center for Health Policy at Duke University View past events of The Value Collaborative here.  
http://catalyst.phrma.org/janssen-pfizer-walgreens-and-other-ceos-discuss-value-in-the-future-of-health-care

10 Things You Should Know About Medicine Spending and Costs

PhRMA  |  Graphic

Many patients struggle to access the medicine they need and have important questions about their costs. 
https://www.phrma.org/graphic/10-things-you-should-know-about-medicine-spending-and-costs

New surveys find payers and providers want more data from biopharmaceutical companies

PhRMA  |  Blog Post

With the right safeguards in place, allowing more flexibility for biopharmaceutical company communications with payers and providers can support better informed prescribing and more effective use of medicines, improving results for patients and protecting public health.
http://catalyst.phrma.org/new-surveys-find-payers-and-providers-want-more-data-from-biopharmaceutical-companies

Senior Director of Infrastructure and Operations

PhRMA  |  PhRMA Career

The Senior Director of Infrastructure and Operations is responsible for: Planning and directing the design, deployment, and implementation of on premise and cloud technology infrastructure, including information security, network administration, device management, system architecture, telecommunications, and business continuity and disaster recovery; Developing and documenting best practices, standards, “as built” diagrams, network segmentation and configuration, and security operations; Responsible for providing a high-level of Tier 1, 2 and 3 customer support; Supporting a mixed client Windows and Mac environment; Managing multiple service providers and ensuring seamless coordination among them; Supervising and mentoring junior staff; Developing and managing service level agreements; Communicating to the organization network and systems downtime, changes, and new services; Being available after hours and on weekends to facilitate network and systems upgrades and maintenance as well as address emergency network problems.
https://www.phrma.org

Medicare Monday: Catch up on MedPAC and its Part B recommendations

PhRMA  |  Blog Post

Put Part B spending on medicines into perspective and learn the facts.
http://catalyst.phrma.org/medicare-monday-catch-up-on-medpac-and-its-part-b-recommendations

PhRMA Calls for Repeal of the Ensuring Patient Access and Effective Drug Enforcement Act of 2016

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $65.5 billion in 2016 alone.
https://www.phrma.org/press-release/phrma-calls-for-repeal-of-the-ensuring-patient-access-and-effective-drug-enforcement-act-of-2016

PhRMA Statement on Dr. Scott Gottlieb’s Nomination to Lead the U.S. Food and Drug Administration

PhRMA  |  Press Release

Gottlieb in his new role and engaging with him and the Agency as they seek to modernize the drug discovery and review process and advance competition in the biopharmaceutical market.”
https://www.phrma.org/press-release/phrma-statement-on-dr-scott-gottlieb-s-nomination-to-lead-the-u-s-food-and-drug-administration

Medicare Monday: A discussion on affordability and access to medicines

PhRMA  |  Blog Post

All American patients and their caregivers deserve this commitment.”
http://catalyst.phrma.org/medicare-monday-a-discussion-on-affordability-and-access-to-medicines

New First-of-Its-Kind Study Shows Growing Share of Medicine List Prices Going to Rebates and Supply Chain

PhRMA  |  Press Release

About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives.
https://www.phrma.org/press-release/new-first-of-its-kind-study-shows-growing-share-of-medicine-list-prices-going-to-rebates-and-supply-chain

190 Medicines in Development for Heart Disease and Stroke

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/190-medicines-in-development-for-heart-disease-and-stroke

New video: Patient and researcher fight JRA together

PhRMA  |  Blog Post

Learn more about the researchers, patients and breakthroughs in progress at .innovation.org/?
http://catalyst.phrma.org/new-video-patient-and-researcher-fight-jra-together

Fighting disease Together: New ads feature patients and the researchers behind today’s breakthroughs

PhRMA  |  Blog Post

Learn more about the researchers, patients and breakthroughs in progress at Innovation.org.  
http://catalyst.phrma.org/fighting-disease-together-new-ads-feature-patients-and-the-researchers-behind-todays-breakthroughs

Biopharmaceutical industry policies aim to increase access to clinical trial data

PhRMA  |  Blog Post

The biopharmaceutical industry believes that disclosure of clinical trial results and appropriate sharing of clinical trial data is in the best interests of patients, clinicians, medical research and the biopharmaceutical industry. 
http://catalyst.phrma.org/biopharmaceutical-industry-policies-aim-to-increase-access-to-clinical-trial-data

ICYMI: Survey highlights key barriers limiting number and scale of new approaches to paying for medicines

PhRMA  |  Blog Post

Allow a full range of truthful and non-misleading communications between innovators and payers for all medically accepted uses of medicines.
http://catalyst.phrma.org/icymi-survey-highlights-key-barriers-limiting-number-and-scale-of-new-approaches-to-paying-for-medicines

ICYMI: Survey highlights key barriers limiting number and scale of new approaches to paying for medicines

PhRMA  |  Blog Post

Allow a full range of truthful and non-misleading communications between innovators and payers for all medically accepted uses of medicines.
http://catalyst.phrma.org/icymi-survey-highlights-key-barriers-limiting-number-and-scale-of-new-approaches-to-paying-for-medicines

You have reviewed the first 75 results out of 2501. Each page contains 25 results. You're on page 3.

prev 1 2 3 4 5 6 next